Cargando…

2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses

BACKGROUND: Tedizolid (TED) is a newly-approved oxazolidinone antibiotic that may be better tolerated than linezolid; however, real-world clinical data are limited, particularly among patients receiving prolonged treatment courses. Our objective was to review our clinical experience with TED and des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marini, Rachel V, Clarke, Lloyd, Shields, Ryan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254022/ http://dx.doi.org/10.1093/ofid/ofy210.2074

Ejemplares similares

1627. Tedizolid is Well-tolerated Among Patients Receiving Prolonged Treatment Courses, Including Those Who are Intolerant of Alternative Agents
por: Smith, Brandon, et al.
Publicado: (2020)

1289. Assessing the Safety and Efficacy with Prolonged Use of Tedizolid in Orthopedic Patients
por: Garza, Daniel E, et al.
Publicado: (2023)

306. Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections
por: Launer, Bryn, et al.
Publicado: (2018)

2421. Efficacy of Secondary Prophylaxis with Oral Vancomycin in Preventing Recurrent Clostridioides difficile Infections in Patients Receiving Systemic Antibiotics
por: Pillinger, Kelly E, et al.
Publicado: (2019)

2287. Real-world Use of Tedizolid Phosphate: A Case Series of Long-Term Tolerability
por: Morrisette, Taylor, et al.
Publicado: (2019)

Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study
por: Senneville, Eric, et al.
Publicado: (2020)

Characteristics of Tedizolid Non-susceptible Enterococcal Clinical Isolates
por: Dhand, Abhay, et al.
Publicado: (2017)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

Selection of a Microprocessor for the Successor of the ACC 2421
por: Heinze, W, et al.
Publicado: (1982)

Safety and tolerability of tedizolid as oral treatment for bone and joint infections
por: Miller, Loren G., et al.
Publicado: (2023)

Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course vs Prolonged-Course Antibiotic Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

User’s manual for the auxiliary crate controller - ACC 2421
por: Heinze, W
Publicado: (1980)

1578. Rifampicin Reduces Tedizolid Concentrations When Co-Administered in Healthy Volunteers
por: Lee, Lawrence, et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Tedizolid
por: Iqbal, Khalid, et al.
Publicado: (2022)

The ACC 2421: a versatile CAMAC crate controller and computer
por: Guillaume, C, et al.
Publicado: (1980)

The ACC 2421 - A Versatile CAMAC Crate Controller and Computer
por: Heinze, W.
Publicado: (1980)

656. Prioritizing Gram-Negative Bacteremia (GNB) Cases for Rapid Detection by β-Lactam Resistance (BLR) and Patient Outcomes
por: McCreary, Erin K, et al.
Publicado: (2019)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

712. Identification of a Novel Tedizolid Resistance Mutation in rpoB of Methicillin-Resistant Staphylococcus aureus
por: Werth, Brian, et al.
Publicado: (2018)

Activity of Tedizolid against Gram-Positive Clinical Isolates Causing Nosocomial- and Community-Acquired Infections in United States Hospitals (2014–2016)
por: Mendes, Rodrigo E, et al.
Publicado: (2017)

1528. A Real-World Perspective on Treatment of CRE UTIs With Oral Agents
por: Babiker, Ahmed, et al.
Publicado: (2018)

1096. Linezolid versus Tedizolid for the Treatment of Nontuberculous Mycobacteria in Solid Organ Transplant Recipients: An Assessment of Safety
por: Poon, Yi Kee, et al.
Publicado: (2020)

1083. Clinical Efficacy of Tedizolid for the Treatment of Mycobacterium abscessus complex Infections in Solid Organ Transplant Recipients
por: Poon, Yi Kee, et al.
Publicado: (2020)

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections
por: Babiker, Ahmed, et al.
Publicado: (2018)

2421 Development and validation of a translational rat model of neonatal abstinence syndrome
por: Brents, Lisa, et al.
Publicado: (2018)

212. Outcomes of Adults with Uncomplicated Staphylococcus aureus Bacteremia Receiving Short-Course Vs. Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2019)

QTc Prolongation in Patients Receiving Triazoles and Amiodarone
por: Cook, Katherine, et al.
Publicado: (2017)

1709. Epidemiology of Invasive Fungal Infection (IFI) after Severe Influenza Requiring Intensive Care Unit (ICU) Admission: 10-Year Experience at a Tertiary Care Center in the United States
por: Viehman, J Alex, et al.
Publicado: (2019)

In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
por: Zhang, Huiyun, et al.
Publicado: (2022)

2410. Clinical outcomes and antimicrobial management strategies of Pseudomonas endocarditis
por: Shah, Sunish, et al.
Publicado: (2023)

Tedizolid Phosphate: a Next-Generation Oxazolidinone
por: Rybak, Jeffrey M., et al.
Publicado: (2015)

Tedizolid: new data and experiences for clinical practice
por: Lletí, Miguel Salavert, et al.
Publicado: (2021)

471. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate (TZD) in Adolescents with Acute Bacterial Skin and Skin Structure Tissue Infections (ABSSSI)
por: Bradley, John S, et al.
Publicado: (2019)

1071. Impact of Standard vs. Prolonged Courses of Antibiotics for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia (SAB) in Patients With Hematologic Malignancies
por: Cheung, Edna, et al.
Publicado: (2018)

Sequence variant at 8q24.21 associates with sciatica caused by lumbar disc herniation
por: Bjornsdottir, Gyda, et al.
Publicado: (2017)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

1116. Comparison of Short-Course vs. Prolonged-Course Antimicrobial Therapy in the Management of Intra-Abdominal Infections
por: Phlamon, Mina, et al.
Publicado: (2018)

2775. Clinical Outcomes and Treatment-Emergent Resistance of Piperacillin-tazobactam, Cefepime, Carbapenems and Fluoroquinolones for the Treatment of Bloodstream Infections due to AmpC β-Lactamase-Producing Enterobacterales
por: Jawanda, Jasanjeet, et al.
Publicado: (2023)

2841. A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate (TZD) and Linezolid (LZD) for Treatment of Ventilated Gram-Positive (G+) Nosocomial Pneumonia
por: Wunderink, Richard G, et al.
Publicado: (2019)

144. Impact of Rapid Identification and Resistance Gene Detection using an Algorithm-Based Approach in Gram-Negative Bacteremia
por: Jawanda, Jasanjeet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u0gluk80l6ov5mianvp3j1c3ge